Differentiation of basal insulins in randomized clinical trials in T2DM subjects: a model-based meta-analysis of HbA1c and hypoglycemic event rates

被引：0
|
作者：
Vaddady, Pavan [1 ]
Lovern, Mark [2 ]
Lommerse, Jos [2 ]
Fancourt, Craig [1 ]
Kandala, Bhargava [1 ]
Mandema, Jaap [2 ]
Gheyas, Ferdous [1 ]
Kerbusch, Thomas [2 ]
Visser, Sandra A. G. [1 ]
机构：
[1] Merck & Co Inc, Kenilworth, NJ USA
[2] Certara Strateg Consultancy, Kenilworth, NJ USA
来源：
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 2017年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
T-032
引用
收藏
页码：S69 / S69
页数：1
相关论文
共 50 条
  • [31] Effect of garlic supplement in the management of type 2 diabetes mellitus (T2DM): a meta-analysis of randomized controlled trials
    Wang, Juan
    Zhang, Xiuming
    Lan, Haili
    Wang, Weijia
    FOOD & NUTRITION RESEARCH, 2017, 61
  • [32] Large dosage Huangqin (Scutellaria) and Huanglian (Rhizoma Coptidis) for T2DM A protocol of systematic review and meta-analysis of randomized clinical trials
    Huang, Xiaoying
    Wang, Lizhen
    Yue, Rensong
    Ding, Ning
    Yang, Hongjing
    MEDICINE, 2020, 99 (38) : E22032
  • [33] A Model-Based Longitudinal Meta-Analysis of FEV1 in Randomized COPD Trials
    Korell, J.
    Martin, S. W.
    Karlsson, M. O.
    Ribbing, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 (03) : 315 - 324
  • [34] Baseline HbA1c Level Correlates with Vildagliptin's Efficacy for T2DM Treatment: A Subgroup Analysis of VISION Study
    Ji, Li Nong
    Zhou, Ling Li
    Pan, Chang Yu
    Lu, Ju Ming
    Wang, Le
    Wang, Bin Hui
    He, James
    DIABETES, 2017, 66 : A628 - A628
  • [35] PATIENT PERCEPTIONS OF CHRONIC ILLNESS CARE AND HBA1C IN DIVERSE T2DM ADULTS: A CROSS-SECTIONAL ANALYSIS
    Clark, Taylor L.
    Fortmann, Addie L.
    Savin, Kimberly L.
    Bravin, Julia I.
    Sandoval, Haley
    Euyoque, Johanna
    Spierling, Samantha
    Philis-Tsimikas, Athena
    Gallo, Linda C.
    PSYCHOSOMATIC MEDICINE, 2020, 82 (06): : A95 - A96
  • [36] Meta-analysis of Active Placebo Response on Glycosylated Haemoglobin (HbA1c) in Type II Diabetes Clinical Trials
    Checchio, Tina Marie
    O'Gorman, Melissa
    Sweeney, Kevin
    Tensfeldt, Tom
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2014, 41 : S28 - S29
  • [37] Consistent Weight Changes Irrespective of Baseline HbA1c with the Combination of Empagliflozin/Linagliptin (EMPA/LINA) in Subjects with Type 2 Diabetes (T2DM)
    Barnett, Anthony H.
    Defronzo, Ralph A.
    Lewin, Andrew
    Patel, Sanjay
    Liu, Dacheng
    Kaste, Renee
    Broedl, Uli C.
    Lee, Christopher
    DIABETES, 2015, 64 : A656 - A656
  • [38] The effectiveness of theory- and model-based lifestyle interventions on HbA1c among patients with type 2 diabetes: a systematic review and meta-analysis
    Doshmangir, P.
    Jahangiry, L.
    Farhangi, M. A.
    Doshmangir, L.
    Faraji, L.
    PUBLIC HEALTH, 2018, 155 : 133 - 141
  • [39] GLP-1 receptor agonists and HBA1c target of <7% in type 2 diabetes: meta-analysis of randomized controlled trials
    Esposito, K.
    Mosca, C.
    Brancario, C.
    Chiodini, P.
    Ceriello, A.
    Giugliano, D.
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (08) : 1519 - 1528
  • [40] Model-based meta-analysis of HbA1c reduction across SGLT2 inhibitors using dose adjusted by urinary glucose excretion
    Sato, Hiromi
    Ishikawa, Ayana
    Yoshioka, Hideki
    Jin, Ryota
    Sano, Yamato
    Hisaka, Akihiro
    SCIENTIFIC REPORTS, 2024, 14 (01):
12345